Sfoglia per Rivista ONCOGENE
THE MET/HGF RECEPTOR IS OVER-EXPRESSED IN HUMAN OSTEOSARCOMAS AND IS ACTIVATED BY EITHER A PARACRINE OR AN AUTOCRINE CIRCUIT
1995-01-01 Ferracini, Riccardo; Direnzo, Mf; Scotlandi, K; Baldini, N; Olivero, M; Lollini, P; Cremona, O; Campanacci, M; Comoglio, Pm
The multiple endocrine neoplasia type 2B point mutation switches the specificity of the Ret tyrosine kinase towards cellular substrates that are susceptible to interact with Crk and Nck.
1997-01-01 Bocciardi, Renata; Mograbi, B; Pasini, B; Borrello, Mg; Pierotti, Ma; Bourget, I; Fischer, S; Romeo, G; Rossi, B.
New pyrazolo[3,4-d]pyrimidine SRC inhibitors induce apoptosis in mesothelioma cell lines through p27 nuclear stabilization
2012-01-01 Indovina, P; Giorgi, F; Rizzo, V; Khadang, B; Schenone, Silvia; Di Marzo, D; Forte, Im; Tomei, V; Mattioli, E; D'Urso, V; Grilli, B; Botta, M; Giordano, A; Pentimalli, F.
NF-κB-dependent cytokine secretion controls Fas expression on chemotherapy-induced premature senescent tumor cells
2011-01-01 Crescenzi, E; Pacifico, F; Lavorgna, A; DE PALMA, Raffaele; D'Aiuto, E; Palumbo, G; Formisano, S; Leonardi, A.
PHOX2B mutations and genetic predisposition to neuroblastoma
2005-01-01 Perri, P.; Bachetti, T.; Longo, L.; Matera, I.; Seri, M.; Tonini, G. P.; Ceccherini, I.
The rat tyrosine phosphatase eta activates c-src to increase cell-substratum adhesion through FAK and paxillin tyrosine phosphorylation: possible implications in human carcinogenesis
2005-01-01 I, LE PERA; R, Iuliano; Florio, T.; C, Susini; F, Trapasso; G, Schettini; M, Santoro; L, Chiariotti; G, Viglietto; A, Fusco
RET activation by germline MEN2A and MEN2B mutations
1995-01-01 Borrello, M. G.; Smith, D. P.; Pasini, B.; Bongarzone, I.; Greco, A.; Lorenzo, M. J.; Arighi, E.; Miranda, C.; Eng, C.; Alberti, L.; Bocciardi, R.; Mondellini, P.; Scopsi, L.; Romeo, G.; Ponder, B. A. J.; Pierotti, M. A.
Retrogenic expression of the MET proto-oncogene correlates with the invasive phenotype of human rhabdomyosarcomas
1996-01-01 Ferracini, Riccardo; Olivero, M; Direnzo, Mf; Martano, M; Degiovanni, C; Nanni, P; Basso, G; Scotlandi, K; Lollini, Pl; Comoglio, Pm
TGFa expression impairs Trastuzumab-induced HER2 down-regulation
2005-01-01 Valabrega, C.; Montemurro, F.; Sarotto, I.; Petrelli, A.; Rubini, P.; Tacchetti, Carlo; Aglietta, M.; Comoglio, P. M.; Giordano, S.
THE PHYSICAL MAP OF THE HUMAN RET PROTO-ONCOGENE. ONCOGENE.
1995-01-01 Pasini, B; Hofstra, Rm; Yin, L; Bocciardi, Renata; Santamaria, G; Grootscholten, Pm; Ceccherini, I; Patrone, G; Priolo, M; Buys, Ch; Romeo, G.
The rat tyrosine phosphatase eta increases cell adhesion by activating c-Src through dephosphorylation of its inhibitory phosphotyrosine residue
2005-01-01 Pera, Il; Iuliano, R; Florio, T; Susini, C; Trapasso, F; Santoro, M; Chiariotti, L; Schettini, Gennaro; Viglietto, G; Fusco, A.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| THE MET/HGF RECEPTOR IS OVER-EXPRESSED IN HUMAN OSTEOSARCOMAS AND IS ACTIVATED BY EITHER A PARACRINE OR AN AUTOCRINE CIRCUIT | 1-gen-1995 | Ferracini, Riccardo; Direnzo, Mf; Scotlandi, K; Baldini, N; Olivero, M; Lollini, P; Cremona, O; Campanacci, M; Comoglio, Pm | |
| The multiple endocrine neoplasia type 2B point mutation switches the specificity of the Ret tyrosine kinase towards cellular substrates that are susceptible to interact with Crk and Nck. | 1-gen-1997 | Bocciardi, Renata; Mograbi, B; Pasini, B; Borrello, Mg; Pierotti, Ma; Bourget, I; Fischer, S; Romeo, G; Rossi, B. | |
| New pyrazolo[3,4-d]pyrimidine SRC inhibitors induce apoptosis in mesothelioma cell lines through p27 nuclear stabilization | 1-gen-2012 | Indovina, P; Giorgi, F; Rizzo, V; Khadang, B; Schenone, Silvia; Di Marzo, D; Forte, Im; Tomei, V; Mattioli, E; D'Urso, V; Grilli, B; Botta, M; Giordano, A; Pentimalli, F. | |
| NF-κB-dependent cytokine secretion controls Fas expression on chemotherapy-induced premature senescent tumor cells | 1-gen-2011 | Crescenzi, E; Pacifico, F; Lavorgna, A; DE PALMA, Raffaele; D'Aiuto, E; Palumbo, G; Formisano, S; Leonardi, A. | |
| PHOX2B mutations and genetic predisposition to neuroblastoma | 1-gen-2005 | Perri, P.; Bachetti, T.; Longo, L.; Matera, I.; Seri, M.; Tonini, G. P.; Ceccherini, I. | |
| The rat tyrosine phosphatase eta activates c-src to increase cell-substratum adhesion through FAK and paxillin tyrosine phosphorylation: possible implications in human carcinogenesis | 1-gen-2005 | I, LE PERA; R, Iuliano; Florio, T.; C, Susini; F, Trapasso; G, Schettini; M, Santoro; L, Chiariotti; G, Viglietto; A, Fusco | |
| RET activation by germline MEN2A and MEN2B mutations | 1-gen-1995 | Borrello, M. G.; Smith, D. P.; Pasini, B.; Bongarzone, I.; Greco, A.; Lorenzo, M. J.; Arighi, E.; Miranda, C.; Eng, C.; Alberti, L.; Bocciardi, R.; Mondellini, P.; Scopsi, L.; Romeo, G.; Ponder, B. A. J.; Pierotti, M. A. | |
| Retrogenic expression of the MET proto-oncogene correlates with the invasive phenotype of human rhabdomyosarcomas | 1-gen-1996 | Ferracini, Riccardo; Olivero, M; Direnzo, Mf; Martano, M; Degiovanni, C; Nanni, P; Basso, G; Scotlandi, K; Lollini, Pl; Comoglio, Pm | |
| TGFa expression impairs Trastuzumab-induced HER2 down-regulation | 1-gen-2005 | Valabrega, C.; Montemurro, F.; Sarotto, I.; Petrelli, A.; Rubini, P.; Tacchetti, Carlo; Aglietta, M.; Comoglio, P. M.; Giordano, S. | |
| THE PHYSICAL MAP OF THE HUMAN RET PROTO-ONCOGENE. ONCOGENE. | 1-gen-1995 | Pasini, B; Hofstra, Rm; Yin, L; Bocciardi, Renata; Santamaria, G; Grootscholten, Pm; Ceccherini, I; Patrone, G; Priolo, M; Buys, Ch; Romeo, G. | |
| The rat tyrosine phosphatase eta increases cell adhesion by activating c-Src through dephosphorylation of its inhibitory phosphotyrosine residue | 1-gen-2005 | Pera, Il; Iuliano, R; Florio, T; Susini, C; Trapasso, F; Santoro, M; Chiariotti, L; Schettini, Gennaro; Viglietto, G; Fusco, A. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile